Pricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Financials
  4. Stock-based compensation

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 20230-89.12%
Dec 31, 20221-46.33%
Dec 31, 20213+113.31%
Dec 31, 20201+215.31%
Dec 31, 20190-8.74%
Dec 31, 20180-40.42%
Dec 31, 20171-50.87%
Dec 31, 20162-75.43%
Dec 31, 20156-21.41%
Dec 31, 20148-4.83%
Dec 31, 20138+71.79%
Dec 31, 20125+46.40%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)